PROPHYL Ltd.
Serving human and animal health since 1991
Our company was founded in 1991 by Dr. János Benyeda and his wife. Their mission, to serve animal and human health, is what has driven the company's development ever since. Our laboratories work in accordance with the GMP and GLP regulations, and our aim is to serve partners as a professional and decisive enterprise in the field of veterinary research & development and production. We also provide a wide range of services as a veterinary CRO (Contract Research Organization) as well as the production method of site-specific vaccines/inactivated veterinary (autogenous) vaccines.
BUSINESS UNITS
SPF egg production
We produce 9-10 million eggs per year, and currently work with three light-bodied laying hen genetics that produce high quality eggs with white shells.
Transport and logistics
We cover 98% of deliveries of our productions throughout Europe – always on time, in perfect condition considering the highest hygiene standards, the appropriate temperature and delivery times. We also got the IFS logistics certification this year.
Veterinary CRO services
We provide wide range of
Infrastructure:
We have BSL-2 and BSL-3 biosecurity level animal houses. The BSL-3 facility has four fully segregated animal enclosures for the housing of animals, each equipped with a vestibule and a handling area. Each unit has a floor area of 16 m2 dedicated to animal housing, either in a deep-litter, grid floor, battery or cage housing system, depending on the requirements of the test and the breed.
Veterinary laboratory services (diagnostics)
We provide comprehensive and continuously expanding range of diagnostic services for commercial livestock. Our modern laboratory facility brings together all the relevant diagnostic services: pathology, microbiology, serology, virology and molecular biology.
CMO services
For over thirty years we have been providing services to veterinary and human vaccine producers. Our main CMO activities:
As a contract manufacturing organization, we welcome enquiries from our present and potential future partners involved in the production of active pharmaceutical ingredients and in pharmaceutical research and development.